Analystreport

Eton Pharmaceuticals (NASDAQ:ETON) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Eton Pharmaceuticals, Inc.  (ETON) 
Last eton pharmaceuticals, inc. earnings: 3/5 04:02 pm Check Earnings Report